Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Quartette side effects?Patent tenofovir alafenamide gilead?Somatuline generic name?Pramlintide approval date?
See the DrugPatentWatch profile for Trelegy
Prices for Trelegy Ellipta vary a lot by country, pharmacy, and insurance coverage. There isn’t a single universal price. If you want a rough idea: - United States (cash price): commonly in the several-hundred-dollar range for one 30-dose inhaler (often around $650–$750). With private insurance or Medicare, the out-of-pocket is usually lower and can be from $0–$100+ per month, depending on your plan. GSK also offers savings programs that can reduce costs for eligible commercially insured patients. - United Kingdom: through the NHS, patients usually pay the standard prescription charge per item (England around £9–£10 as of recent years; exemptions apply). In Scotland, prescriptions are free. - Canada: prices vary by province; the out-of-pocket price without insurance is typically several hundred Canadian dollars per inhaler. Notes: - Trelegy Ellipta is brand-name only (no generic yet in most markets), so price differences are driven by insurance and pharmacy pricing rather than substitution. - Savings programs and patient-assistance options are often available to reduce out-of-pocket costs. If you tell me your country and whether you have insurance (and your approximate pharmacy), I can give a more precise estimate and point you to savings options.
Other Questions About Trelegy :